Bioscreen Health partner with INFANT centre to make pregnancy safer

Expectant mums cannot wait to hold their bundle of joy but for many, the highly-anticipated moment can be painful, messy, and far from smooth sailing.

Now, University College Cork research may lead to huge improvements globally in the care of expectant mothers.

A new projePregnantGenericPA_largect, LEANBH, launched yesterday in Cork University Maternity Hospital, is designed to make pregnancy safer.

The Irish Centre for Foetal and Neonatal Translational Research (INFANT) is heading the project in association with BioScreen Health, Laya Healthcare and IBM Ireland.

Prof Louise Kenny, consultant obstetrician and director of INFANT, said:

“This technology has the potential to revolutionise antenatal care for expectant mothers on a global scale and is another example of the cutting-edge research ongoing at INFANT.”

LEANBH research is a pilot project to provide remote healthcare monitoring to expectant mothers in order to improve the detection and treatment of hypertension and pre-eclampsia.

Speaking at the launch, Dónal Clancy of Laya Healthcare said: “If an expectant mother does experience hypertension or pre-eclampsia we want to be able to support her and her wider family in the best way possible. Through LEANBH we hope the treatment she needs can be delivered in the safety and comfort of her home.”

LEANBH envisages reducing the number of unnecessary follow-on hospital visits, lowering the additional stress and cost of visits both to the patients and the healthcare system.

Healthcare researchers will be able to use predictive modelling, trending, and scoring to anticipate patient outcomes and evaluate the potential effects of early interventions.

The research data from the pilot study will also provide capabilities to the centre for devising new predictive models of perinatal healthcare monitoring which can be used to identify and improve the outcome of pregnancy for both mothers and their babies.

Russell Quigley from BioScreen Health said it was their mission to improve the health of customers. “Our goal is to offer quality service and programmes that set standards, exceed patient expectations and are provided in a convenient, cost-effective and accessible manner. We look forward to contributing to the LEANBH project and being part of this incredible innovation.”

Bioscreen Health receives Seed Funding from NDRC

NDRC-LaunchPad-12-718x523The National Digital Research Centre (NDRC) has announced the 12th batch of start-ups receiving support at the Digital Hub, as the LaunchPad accelerator continues to shine.

Receiving office space in the Digital Hub, €20,000 in pre-seed investment and three months of mentorship, the 10 new residents in Dublin 8 have just been announced – one of the new start-ups sources furniture or décor seen on TV shows, which sounds amazing.

All with digital innovations at their core, they will join an accelerator programme ranked 2nd in the world.

In fact, NDRC has a portfolio of start-up ventures that have now raised a combined €88m in investment.

“LaunchPad is a first step on the road to building a viable and sustainable technology business for these talented and innovative entrepreneurs,” said Gary Leyden, VP of NDRC’s venture acceleration.

“NDRC works with them to develop their proof of concept and refine their business model so that they can evolve into an investable venture that will attract follow-on funding from the broader investment community.”

This story was originally published at 10.52 on 8 Septemher 2015. It has since been updated: This article was amended to include Bioscreen Health as one of the new ventures.